NASDAQ:ARMO Investor Alert: Investigation over Possible Wrongdoing in Acquisition of ARMO BioSciences, Inc
May 14, 2018 at 12:00 PM EDT
San Diego, CA -- (SBWIRE) -- 05/14/2018 -- An investigation was announced for investors, who currently hold shares of ARMO BioSciences, Inc. (NASDAQ: ARMO),over the takeover of ARMO BioSciences, Inc. by Eli Lilly and Company for $50.00 per share is unfair to NASDAQ: ARMO stockholders.
